I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Faramand, Rawan
110
results:
Online X
Search for persons
X
Format
Online (110)
Mediatypes
Articles (Online) (66)
OpenAccess-fulltext (44)
Sorted by: Relevance
Sorted by: Year
?
1
Sirolimus Is an Acceptable Alternative to Tacrolimus for Gr..:
Elmariah, Hany
;
Otoukesh, Salman
;
Kumar, Ambuj
...
Transplantation and Cellular Therapy. 30 (2024) 2 - p. 229.e1-229.e11 , 2024
Link:
https://doi.org/10.1016/..
?
2
Mismatched donor allogeneic hematopoietic cell transplantat..:
Caprice, Teresa
;
Fan, Wenyi
;
Kim, Jongphil
...
American Journal of Hematology. 99 (2024) 6 - p. 1196-1200 , 2024
Link:
https://doi.org/10.1002/..
?
3
Hypomethylating Agents and Venetoclax for Acute Myeloid Leu..:
Ionescu, Filip
;
David, Jerel C.
;
Ravichandran, Apoorva
...
Clinical Lymphoma Myeloma and Leukemia. 24 (2024) 6 - p. 400-406 , 2024
Link:
https://doi.org/10.1016/..
?
4
MM-059 Incidence and Risk Factors Associated With Bleeding ..:
Mohammed, Turab
;
Peres, Lauren
;
Colinleitzinger, Christelle
...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S473-S474 , 2023
Link:
https://doi.org/10.1016/..
?
5
P1540: COVID-19 INFECTION AMONG CAR-T CELL THERAPY RECIPIEN..:
Din, Mohammad Ammad Ud
;
Oh, Nayeon
;
Baluch, Aliyah
...
HemaSphere. 7 (2023) S3 - p. e971246c , 2023
Link:
https://doi.org/10.1097/..
?
6
Belumosudil Impacts Immunosuppression Pharmacokinetics in P..:
Gonzalez, Rebecca
;
Gaskill, Eric
;
Padilla, Maya
...
Transplantation and Cellular Therapy. 29 (2023) 9 - p. 577.e1-577.e9 , 2023
Link:
https://doi.org/10.1016/..
?
7
POSTER: MM-059 Incidence and Risk Factors Associated With B..:
Mohammed, Turab
;
Peres, Lauren
;
Colinleitzinger, Christelle
...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S216 , 2023
Link:
https://doi.org/10.1016/..
?
8
Cardiac events after standard of care idecabtagene vicleuce..:
Lee, Dae Hyun
;
Kumar, Abhishek
;
Mohammed, Turab
...
Blood Advances. 7 (2023) 16 - p. 4247-4257 , 2023
Link:
https://doi.org/10.1182/..
?
9
Cardiac and inflammatory biomarker differences in adverse c..:
Lee, Dae Hyun
;
Chandrasekhar, Sanjay
;
Jain, Michael D.
...
Cardio-Oncology. 9 (2023) 1 - p. , 2023
Link:
https://doi.org/10.1186/..
?
10
Feasibility and Toxicity of Full-Body Volumetric Modulated ..:
Keit, Emily
;
Liveringhouse, Casey
;
Figura, Nicholas
...
Technology in Cancer Research & Treatment. 22 (2023) - p. 153303382311807 , 2023
Link:
https://doi.org/10.1177/..
?
11
P356: PHASE 1/2 DOSE-ESCALATION STUDY OF ANTI-CD7 ALLOGENIC..:
Ghobadi, Armin
;
Aldoss, Ibrahim
;
Maude, Shannon
...
HemaSphere. 7 (2023) S3 - p. e1789302 , 2023
Link:
https://doi.org/10.1097/..
?
12
PB2092: INCIDENCE AND RISK FACTORS ASSOCIATED WITH BLEEDING..:
Mohammed, Turab
;
Shahzad, Moazzam
;
Peres, Lauren
...
HemaSphere. 7 (2023) S3 - p. e46377e2 , 2023
Link:
https://doi.org/10.1097/..
?
13
Outcomes of CD19-Targeted Chimeric Antigen Receptor T Cell ..:
Wood, Anthony C.
;
Perez, Ariel Perez
;
Arciola, Brian
...
Transplantation and Cellular Therapy. 28 (2022) 12 - p. 829.e1-829.e8 , 2022
Link:
https://doi.org/10.1016/..
?
14
A phase 2 multicenter trial of ofatumumab and prednisone as..:
Lazaryan, Aleksandr
;
Lee, Stephanie
;
Arora, Mukta
...
Blood Advances. 6 (2022) 1 - p. 259-269 , 2022
Link:
https://doi.org/10.1182/..
?
15
Outcomes Following Intolerance to Tacrolimus/Sirolimus Graf..:
Mirza, Abu-Sayeef
;
Tandon, Ankita
;
Jenneman, Dakota
...
Transplantation and Cellular Therapy. 28 (2022) 4 - p. 185.e1-185.e7 , 2022
Link:
https://doi.org/10.1016/..
1-15